1. Home
  2. LXFR vs RCKT Comparison

LXFR vs RCKT Comparison

Compare LXFR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$17.07

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.04

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
RCKT
Founded
1898
1999
Country
United States
United States
Employees
N/A
202
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
401.6M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
LXFR
RCKT
Price
$17.07
$3.04
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$29.73
AVG Volume (30 Days)
120.9K
2.0M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$384,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.01
$64.28
P/E Ratio
$131.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.15
$2.40
52 Week High
$17.18
$5.45

Technical Indicators

Market Signals
Indicator
LXFR
RCKT
Relative Strength Index (RSI) 74.23 38.89
Support Level $14.74 $2.96
Resistance Level N/A $3.52
Average True Range (ATR) 0.53 0.19
MACD 0.08 -0.01
Stochastic Oscillator 91.57 19.27

Price Performance

Historical Comparison
LXFR
RCKT

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: